Dr. Salyka M. Sengsayadeth, MD

Dr. Sengsayadeth practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Sengsayadeth's NPI, 1619024429, was assigned on January 4, 2007. Dr. Sengsayadeth graduated from East Tennessee State University Quillen College of Medicine in 2006. Dr. Sengsayadeth holds Tennessee license 43256.

Dr. Sengsayadeth's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Sengsayadeth's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Sengsayadeth to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sengsayadeth practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sengsayadeth's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sengsayadeth is licensed in Tennessee.

CMS data shows 137 Medicare services from Dr. Sengsayadeth across 2 procedure codes in 2024, all of them office visits, for 67 Medicare patients. Medicare paid $12,302 for them.

CMS counts 67 Medicare patients who saw Dr. Sengsayadeth in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sengsayadeth's median patient age at 72, with 46% women.

In 2024, Dr. Sengsayadeth wrote 310 Medicare Part D claims for 35 patients. 75% of them were for generic drugs. CMS names the drug for 220 of them, across 9 drugs with 11 or more claims each, at $1,348,969 in total drug cost. In 2023, CMS named 174 claims across 7 drugs.

Dr. Sengsayadeth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sengsayadeth as offering telehealth.

Dmand AI links 41 papers to Dr. Sengsayadeth, published from 2012 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation Conditioning. Dr. Sengsayadeth has published most often in Bone Marrow Transplant. Dr. Sengsayadeth's most frequent co-authors are Adetola A. Kassim, MD, Madan Harikishin Jagasia, MD and Bhagirathbhai Ravjibhai Dholaria, MD.

CMS Open Payments shows 8 general payments to Dr. Sengsayadeth from 3 drug and device companies from 2019 to 2023. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 49% of the total. AstraZeneca Pharmaceuticals LP paid the most, $316.

Dr. Sengsayadeth graduated from East Tennessee State University Quillen College of Medicine in 2006.